CTRI/2021/03/032164招募中未知
Prospective study to evaluate the effects of oral branched chain amino acid supplementation on clinical, laboratory parameters, quality of life and the natural course of the disease in patients with cirrhosis of liver
Max Super Speciality Hospital Vaishali0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
入选标准
- •1-Patients diagnosis with cirrhosis of liver.
- •2-Patients who are taking/ who are not taking BCCA supplementation
排除标准
- •1-Patients on dietary protein restriction
- •2-Serum total bilirubin of 3 mg/ dl or higher
- •3-Hepatocellular carcinoma
- •4-Resistant ascites
- •5-Oesohageal varices
- •6-Hepato encephalopathy grade III or higher
研究者
相似试验
招募中
不适用
Prospective observational study for effect of oral nutrition supplement on pressure ulcer healingPressure ulcerJPRN-UMIN000019383utrition Support Center and Wound Ostomy Continence (WOC) Center, Nursing Department of Tohoku University Hospital100
尚未招募
不适用
A pilot study assessing the effectiveness of oral Propranolol in preventing epistasis in patients with Hereditary Haemorrhagic Telangiectasia.Hereditary Haemorrhagic TelangiectasiaHuman Genetics and Inherited Disorders - Other human genetics and inherited disordersCardiovascular - Diseases of the vasculature and circulation including the lymphatic systemACTRN12619001020178Royal brisbane and Women's Hospital15
招募中
不适用
A Prospective Randomized Controlled Study of Oral Tranexamic Acid for Prevention of Postinflammatory Hyperpigmentation after Q-Switched Nd-YAG (532 nm) Lasersolar lentiginespost inflammatory hyperpigmentationpost inflammatory hyperpigmentationsolar lentiginesTCTR20161010004Division of Dermatology, Department of Medicine, Faculty of Medicine Ramathibodi Hospital40
招募中
不适用
The study about the effectiveness of applying oral scanner in impression technique to edentulous patientEdentulous jawJPRN-UMIN000021542Tokyo Medical and Dental University10
已完成
不适用
A study to compare oral cyclosporine and oral corticosteroids in treatment of actively spreading vitiligo.CTRI/2018/07/014732one50
